Antibiotic choice based on hospital lab reports in transplant patients with bloodstream infection
Part of Infections clinical trials.
This study looks at whether choosing antibiotics based on local hospital lab reports (antibiograms) works well for organ transplant patients who have a single bacteria in their bloodstream. It hopes to find the best way to treat these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have received a solid organ transplant (like kidney, liver, heart, or lung).
- Your bloodstream infection was caused by a single type of one of these bacteria: A. baumannii, Enterobacter, E. faecalis, E. faecium, E. coli, Klebsiella (any type), P. mirabilis, P. aeruginosa, Serratia, S. aureus, S. lugdunensis, or Streptococcus.
- You were hospitalized at the Fondazione IRCCS Cà Granda Policlinico in Milan between 2015 and 2023.
- You did NOT receive antibiotics within 48 hours before or after your blood culture sample was taken.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new, faster way to choose the right antibiotic for people with a blood infection caused by Enterobacterales bacteria. The goal is to see if this quick test helps doctors start the most effective treatment sooner.
This trial checks if monitoring antibiotic levels in the blood can help doctors give the right dose to liver transplant patients with serious bacterial infections. The goal is to make the treatment work better.
This study compares two ways of giving preventive antibiotics to liver transplant patients who carry resistant bacteria. The goal is to see if targeted antibiotics work better than standard ones at preventing infections without causing more side effects.
This study tests a careful antibiotic-use program for patients with a bloodstream infection caused by a group of bacteria called Enterobacterales. The goal is to use the right antibiotics for the right amount of time. It may help you get better treatment with fewer side effects.
This trial tests whether switching from IV to oral antibiotics is just as effective for treating Gram-negative bloodstream infections. If you qualify, you may receive either continued IV antibiotics or switch to pills, with follow-up on your recovery and quality of life.
This trial tests if giving a specific antibiotic can help prevent bloodstream infections in people who recently had a kidney transplant. It is for patients who have a significant amount of bacteria in their urine within the first month after surgery.
Hear when a new Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.